Ontario Pharmacy Smoking Cessation Program: More Pharmacies Need to Participate
Author(s): ,
Giulia Consiglio
Affiliations:
BSc MSc
,
Lisa Dolovich
Affiliations:
PharmD MSc
,
Zahava Roseberg-Yunger
Affiliations:
PhD
,
Beth Sproule
Affiliations:
PharmD
,
Michael Chaiton
Affiliations:
PhD
,
Sara Guilcher
Affiliations:
PhD
Suzanne Cadarette
Affiliations:
PhD
Canadian Pharmacists Conference ePoster Library. Wong L. Jun 4, 2017; 174280
Lindsay Wong
Lindsay Wong
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Objectives
The Ontario Pharmacy Smoking Cessation Program was introduced in September 2011 to reimburse pharmacies for smoking cessation counselling services for Ontario Drug Benefit (ODB) eligible individuals. Prescription smoking cessation medications were also added to the ODB formulary in August 2011. We aimed to describe the use of pharmacy smoking cessation services over time, and measure compliance with prescription smoking cessation medication.

Methods
We analyzed medical and pharmacy claims data to identify the number of patients and pharmacies participating; compare patient characteristics over time (2011/09-2013/08 vs. 2013/09-2015/03); and estimate prescription smoking cessation medication compliance (proportion of days covered over 90 days 80%). Analyses were stratified by drug plan group (seniors 65 years; or social assistance <65 years), sex and region.

Results
Forty percent (n=1,710) of Ontario pharmacies participated, with 26% being new providers from 2013/09-2015/12. We identified 12,819 patients; patient characteristics remained similar over the two time periods, with 29% seniors (mean age=70, SD=4.7; 53% male) and 71% social assistance (mean age=46, SD=11.7; 49% male). In the year prior to smoking cessation service, almost half received another professional pharmacy service such as MedsCheck (18% at enrolment), and 89% had a physician smoking cessation service. Regional differences in use were identified. North East region had among the lowest prior use of physician smoking cessation services (80%), yet among the highest prior use of professional pharmacy services (55%). Among patients with one-year follow-up data, 58% received follow-up smoking cessation services and 74% received prescription smoking cessation medication. More patients starting prescription smoking cessation medication at enrolment were compliant (37%), compared to patients starting before (25%), or after (12%) enrolment.

Conclusion
More pharmacies offering smoking cessation services may improve patient access to smoking cessation services, particularly in areas with limited access to physicians.

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings